Clinical research progress in autologous hematopoietic stem cell transplantation for malignant lymphoma treatment
10.3969/j.issn.1000-8179.20142170
- VernacularTitle:自体造血干细胞移植治疗恶性淋巴瘤的临床研究进展
- Author:
Yuankai SHI
;
Youwu SHI
- Publication Type:Journal Article
- Keywords:
autologous;
hematopoietic stem cell transplantation;
lymphoma;
treatment
- From:
Chinese Journal of Clinical Oncology
2015;(1):1-7
- CountryChina
- Language:Chinese
-
Abstract:
High-dose therapy (HDT) combined with autologous hematopoietic stem cell transplantation (AHSCT) is a standard treatment for relapsed or refractory aggressive lymphoma. However, the role of HDT/AHSCT in the first-line treatment of lymphoma remains controversial, and related issues about its application in different subtypes of lymphoma should be addressed. This article brief-ly reviewed the clinical progress in AHSCT for malignant lymphoma treatment.
